VERTEX PHARMACEUTICALS, INC.

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

February 11, 1999

Accession Number

0000932471-99-000236

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →